These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 3488191)

  • 21. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections.
    Slevin NJ; Aitken J; Thornley PE
    Lancet; 1984 Apr; 1(8380):782-3. PubMed ID: 6143094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.
    O'Callaghan CH; Morris A; Kirby SM; Shingler AH
    Antimicrob Agents Chemother; 1972 Apr; 1(4):283-8. PubMed ID: 4208895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture.
    Ninane G; Joly J; Kraytman M
    Br Med J; 1978 Feb; 1(6108):276-8. PubMed ID: 620304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro sensitivity to penicillin V and beta-lactamase production of Branhamella catarrhalis.
    Malmvall BE; Brorsson JE; Johnsson J
    J Antimicrob Chemother; 1977 Jul; 3(4):374-5. PubMed ID: 408320
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug therapy reviews: trimethoprim-sulfamethoxazole.
    Gleckman R; Alvarez S; Joubert DW
    Am J Hosp Pharm; 1979 Jul; 36(7):893-906. PubMed ID: 382841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy of otitis media.
    Lisby-Sutch SM; Nemec-Dwyer MA; Deeter RG; Gaur SM
    Clin Pharm; 1990 Jan; 9(1):15-34. PubMed ID: 2406100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical, diagnostic and therapeutic aspects of Moraxella catarrhalis infections].
    Bourgeois F; Lambert-Zechovsky N; Bingen E
    Pathol Biol (Paris); 1993 Jun; 41(6):555-61. PubMed ID: 8247636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The increasing importance of Branhamella catarrhalis in respiratory infections.
    Van Hare GF; Shurin PA
    Pediatr Infect Dis J; 1987 Jan; 6(1):92-4. PubMed ID: 3547295
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapy of acute otitis media caused by Branhamella catarrhalis. Preliminary report.
    Shurin PA; Van Hare GF
    Drugs; 1986; 31 Suppl 3():122-4. PubMed ID: 3488191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media.
    Easton J; Noble S; Perry CM
    Drugs; 2003; 63(3):311-40. PubMed ID: 12534334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial therapy for acute otitis media: a critical analysis.
    Marchant C; Shurin PA
    Rev Infect Dis; 1982; 4(2):506-13. PubMed ID: 7051243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dilemmas in primary care: antibiotic treatment of acute otitis media.
    True BL; Helling DK
    Drug Intell Clin Pharm; 1986 Sep; 20(9):666-9. PubMed ID: 3530681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy of otitis media.
    Thoene DE; Johnson CE
    Pharmacotherapy; 1991; 11(3):212-21. PubMed ID: 1862012
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.